Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
blood sampling (alpha-Galactosidase & LysoGb3)
Takeda
Fabry Disease
1 trial -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
circulate free methylated EBV DNA
The First People's Hospital of Lianyungang
Extranodal Natural Killer/T-cell Lymphoma
1 trial -
circulating tumor cells test
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thyroid Nodule
1 trial -
dexmedetomidine
Sana Biotechnology
Laparoscopic Cholecystectomy
1 trial -
enalapril
Ultragenyx UK Limited
IGA Glomerulonephritis
1 trial -
extensively hydrolyzed rice protein formula
United Therapeutics Europe Ltd
Milk Hypersensitivity
1 trial -
fecal microbiota transplantation
The First People's Hospital of Lianyungang
Fecal Microbiota Transplantation
1 trial -
fludeoxyglucose F 18
United Therapeutics Europe Ltd
Testicular Germ Cell Tumor
1 trial -
intravenous immunoglobulin
The First People's Hospital of Lianyungang
Guillain-Barre Syndrome
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
laronidase
BioMarin Pharmaceutical Australia Pty Ltd
Cognitive Decline
1 trial -
leuprorelin
The First People's Hospital of Lianyungang
Hematopoietic Stem Cell Transplantation
1 trial -
live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
modified BEAM
The First People's Hospital of Lianyungang
Autologous Stem Cell Transplantation
1 trial -
n-3 Polyunsaturated fatty acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
new extensively hydrolysed formula
United Therapeutics Europe Ltd
Protein Allergy
1 trial -
new infant formula
United Therapeutics Europe Ltd
Functional Constipation
1 trial -
parecoxib
The First People's Hospital of Lianyungang
Anti-Inflammatory Agents, Non-Steroidal
1 trial -
placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
PCOS- Polycystic Ovary Syndrome
1 trial -
placebo
CUMBERLAND PHARMACEUTICALS INC
Autism
1 trial -
placebo (compared to vasoconstrictor)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Male
1 trial -
plasmalyte solution
Hospital Authority, Hong Kong
Cardiac Surgery
1 trial -
pre-packaged low-residue diet for bowel preparation
The First People's Hospital of Lianyungang
IBD (Inflammatory Bowel Disease)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources